Relation of peripheral collagen markers to death and hospitalization in patients with heart failure and preserved ejection fraction: results of the I-PRESERVE collagen substudy.
about
Heart failure with preserved ejection fraction: emerging drug strategiesBiomarkers in heart failure with preserved ejection fractionClinical adoption of prognostic biomarkers: the case for heart failureDeveloping therapies for heart failure with preserved ejection fraction: current state and future directionsCirculating fibrosis biomarkers and risk of atrial fibrillation: The Cardiovascular Health Study (CHS)Fibrosis-related biomarkers and incident cardiovascular disease in older adults: the cardiovascular health study.Incremental prognostic significance of the elevated levels of pentraxin 3 in patients with heart failure with normal left ventricular ejection fraction.Matricellular proteins in cardiac adaptation and disease.Integrating the myocardial matrix into heart failure recognition and management.Molecular and cellular basis for diastolic dysfunction.Experimental biomarkers in heart failure: an update.Biomarkers of diastolic dysfunction and myocardial fibrosis: application to heart failure with a preserved ejection fraction.Biomarkers of heart failure with normal ejection fraction: a systematic review.Circulating biomarkers in patients with heart failure and preserved ejection fraction.Heart failure with preserved ejection fraction: a clinical dilemma.Molecular and Digital Biomarker Supported Decision Making in Clinical Studies in Cardiovascular Indications.Heart failure with preserved ejection fraction and skeletal muscle physiology.High serum levels of thrombospondin-2 correlate with poor prognosis of patients with heart failure with preserved ejection fraction.Diastolic heart failure: What we still don't know. Looking for new concepts, diagnostic approaches, and the role of comorbidities.Extracellular cardiac matrix biomarkers in patients with reduced ejection fraction heart failure as predictors of response to cardiac resynchronisation therapy: a systematic review.Insulin-Like Growth Factor-Binding Protein-7 as a Biomarker of Diastolic Dysfunction and Functional Capacity in Heart Failure With Preserved Ejection Fraction: Results From the RELAX Trial.Diagnostic and prognostic value of osteopontin in patients with acute congestive heart failure.Effect of spironolactone on diastolic function in hypertensive left ventricular hypertrophy.Circulating biomarkers of distinct pathophysiological pathways in heart failure with preserved vs. reduced left ventricular ejection fraction.Transitioning from usual care to biomarker-based personalized and precision medicine in heart failure: call for action.Liver fibrosis score predicts mortality in heart failure patients with preserved ejection fraction.Pro-Inflammatory Biomarkers in Stable Versus Acutely Decompensated Heart Failure With Preserved Ejection Fraction.
P2860
Q24595118-EAD6CDC8-6903-4173-A258-11104DC6747CQ26768192-57D9ADD6-C9DD-4F6E-B727-FE70D720C67AQ26863716-0EFF0714-0BEF-462C-9416-CCB612705AFFQ33639223-D5A16D23-C005-44BB-BC0C-561445B395AEQ33765348-52A5D1C6-C0EE-4353-A15D-87FF20F32F3CQ34076151-20193B91-7A32-4905-AFE9-F60E65EE24D4Q35026270-794E1F03-C208-4D45-A249-F992B437316FQ35542423-5A066D38-489D-4503-8505-7C194E926F67Q37406111-BF8FF2CD-D0A6-44FD-8057-F4889FC54611Q38038531-94206448-EB00-4CDC-8682-B138D3D2FDE5Q38055505-020A80C4-2CF9-493C-B0E5-B3D42B777887Q38110226-F0EFDDEF-3D8F-4D45-A781-FA2AC06E68F8Q38120919-1AB61CAD-DCAA-4A18-8F79-3D3B8E6235A9Q38152289-07C3AEF9-C0F6-4983-A844-3595ED3E73DCQ38195149-3E7AC7E6-FAFC-46F9-B86A-91955E62F065Q38815451-F5759432-8518-4765-8555-367568A8EF1FQ38931738-B4421A21-5A8E-4060-8A1E-4B26693A223BQ39140760-DDDC9D8F-B793-4227-B5C5-110EBECB54B0Q39514776-8CF9DD9D-6F40-4998-B747-8482D5D6F324Q41544213-424E1A3A-B62D-4F6F-B48B-0A4C93F62AF5Q42679350-0EE4CD6C-5ABD-4FCB-9F59-DB2CE23A03BAQ43807471-2B177C26-2848-49E9-80AC-869C358C109DQ48210690-D51A2379-0759-4BD6-B986-5B207DC44846Q48725493-4E27E85A-B245-4362-AB9E-88EA31AB07C8Q53502512-6032AE25-5C18-4934-A724-4082A7055546Q55413275-DA691B43-B4D4-4745-B0E4-26BF36FBDFD2Q55499529-5E1C55B5-3FF3-49AA-AD39-CF96EB97B328
P2860
Relation of peripheral collagen markers to death and hospitalization in patients with heart failure and preserved ejection fraction: results of the I-PRESERVE collagen substudy.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Relation of peripheral collage ...... I-PRESERVE collagen substudy.
@en
type
label
Relation of peripheral collage ...... I-PRESERVE collagen substudy.
@en
prefLabel
Relation of peripheral collage ...... I-PRESERVE collagen substudy.
@en
P2093
P50
P1476
Relation of peripheral collage ...... I-PRESERVE collagen substudy.
@en
P2093
Agata Ptaszynska
Barry M Massie
Hans G Schneider
Marion Black
Maros Elsik
Michael R Zile
Peter E Carson
Robert S McKelvie
P304
P356
10.1161/CIRCHEARTFAILURE.110.960716
P577
2011-07-12T00:00:00Z